Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Sore throat Shake-Up: could pharmacists replace doctors for antibiotic decisions?

NCT ID NCT06114706

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether having nurses or pharmacists, instead of doctors, do the first assessment for a sore throat can reduce unnecessary antibiotic use. Researchers will compare how often each type of health professional follows official guidelines. The goal is to see if changing who sees the patient first can safely cut down on antibiotics for sore throats.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could show that shifting initial sore throat assessments to nurses or pharmacists safely reduces unnecessary antibiotic prescriptions.
What could go wrong
This is an observational study, not a treatment trial. Results may not apply outside Sweden, and differences in patient flow may not change prescribing habits as hoped.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 450 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2024

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * The patient is contacting/attending PHC centre or Pharmacy presenting with a sore throat as the main complaint. * Male or female, aged ≥6 years. * Fluent in Swedish (reading, writing, conversational) (applicable to caregivers/parents/guardians in case of children). * Mental state such that he or she can understand and give informed consent to participation in the study by signing the Information and Consent Form. * Provision of signed and dated Informed Consent Form. Exclusion Criteria: * The illness episode is classified as potentially complicated or potentially critically ill * Presence of SARS-CoV-2 virus in a patient first appearing at the PHC in a cluster where the assessment is supposed to be done by the pharmacists. The patient will not be sent to the pharmacist in case of presence of SARS-CoV-2-virus. * Patient request to be withdrawn from the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pharyngitis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    4 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Apoteket

    RECRUITING

    Stenungsund, 4430, Sweden

  • Apoteksgruppen

    RECRUITING

    Ulricehamn, Sweden

  • Närhälsan Stenungsund Vårdcentral

    RECRUITING

    Stenungsund, 44430, Sweden

  • Praktikertjänst Hälsobrunnen Vårdcentral

    RECRUITING

    Ulricehamn, 52337, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.